In the latest trading session, Novo Nordisk (NVO) closed at $38.06, marking a -1.35% move from the previous day. This change lagged the S&P 500's 0.02% loss on the day. On the other hand, the Dow registered a loss of 0.35%, and the technology-centric Nasdaq decreased by 0.15%. The stock of drugmaker has fallen by 11.21% in the past month, lagging the Medical sector's gain of 1.06% and the S&P 500's gain of 2.05%. Analysts and investors alike will be keeping a close eye on the performance of Novo Nordisk in its upcoming earnings disclosure. On that day, Novo Nordisk is projected to report earnings of $0.81 per share, which would represent a year-over-year decline of 20.59%. Meanwhile, our latest consensus estimate is calling for revenue of $11.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。